|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 264.48 USD | +1.62% |
|
-2.08% | -12.95% |
| 12/06 | BeOne Says Updated Results for Cancer Drug Tacabrutideg Show 'Durable' Responses | MT |
| 12/06 | BeOne Medicines Announces New Data From Foundational Hematology Franchise At EHA 2026 | CI |
Chart calendar BeOne Medicines AG
Upcoming events on BeOne Medicines AG
No events available
Past events on BeOne Medicines AG
| 11/06/2026 | Annual General Meeting | 07:00 pm |
| 02/06/2026 | Information meeting | 05:31 am |
| 12/05/2026 | Earnings release - Q1 2026 | |
| 06/05/2026 | Earnings presentation | 05:30 pm |
| 06/05/2026 | Earnings release - Q1 2026 | |
| 06/05/2026 | Earnings release - Q1 2026 | |
| 16/04/2026 | Earnings presentation | 06:30 am |
| 25/03/2026 | Earnings release - Annual 2025 | |
| 26/02/2026 | Board of Directors Meeting | |
| 26/02/2026 | Earnings presentation | 06:30 pm |
| 26/02/2026 | Earnings release - Q4 2025 | |
| 14/11/2025 | Earnings presentation | 06:30 am |
| 06/11/2025 | Earnings release - Q3 2025 | |
| 06/11/2025 | Earnings presentation | 06:30 pm |
| 01/09/2025 | Earnings presentation | 06:30 am |
| 29/08/2025 | Earnings release - Q2 2025 | |
| 06/08/2025 | Earnings presentation | 05:30 pm |
| 06/08/2025 | Earnings release - Q2 2025 | |
| 26/06/2025 | Information meeting | 06:00 pm |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 459 2 414 1.87% | 3 810 3 710 2.7% | 5 343 5 298 0.85% | 6 479 | 7 435 | 8 357 |
|
EBITDA Million USD | Released Forecast Spread | -1 120 -1 105 -1.38% | -396 -523 24.27% | 589 527 11.71% | 1 012 | 1 447 | 2 167 |
|
EBIT Million USD | Released Forecast Spread | -1 208 -1 160 -4.09% | -568 -638 10.91% | 447 377 18.72% | 855 | 1 220 | 1 761 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -826 -905 8.77% | -533 -565 5.59% | 417 399 4.38% | 912 | 1 293 | 1 824 |
|
Net income Million USD | Released Forecast Spread | -882 -911 3.27% | -645 -594 -8.61% | 287 336 -14.53% | 763 | 1 100 | 1 540 |
|
EPS USD | Released Forecast Spread | -8,45 -8,56 1.3% | -6,12 -5,59 -9.54% | 2,53 3,24 -21.96% | 6,70 | 9,66 | 13,0 |
| Announcement Date | 26/02/24 | 27/02/25 | 26/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 681 1 604 4.79% | 1 002 984 1.76% | 1 128 1 039 8.53% | 2 129 2 037 4.54% | 1 117 1 136 -1.67% | 1 315 1 240 6.06% | 2 433 2 353 3.38% | 1 412 1 364 3.54% | 1 498 1 455 2.98% | 2 910 2 930 -0.67% | 1 513 1 437 5.35% | 1 594 | 1 668 | 1 731 | 1 688 | 1 804 | 1 846 | 1 944 | 1 608 |
|
EBITDA Million USD | Released Forecast Spread | -49,0 -282 82.63% | -29,2 -210 86.12% | 43,9 -60,7 172.36% | 123 82,8 49.06% | 200 148 35.26% | 221 211 4.84% | 291 141 105.86% | 225 | 268 | 197 | 337 | 355 | 361 | 391 | 337 | ||||
|
EBIT Million USD | Released Forecast Spread | -369 -455 19.01% | -120 -137 12.07% | -79,4 -161 50.79% | 11,1 -78,5 114.14% | 87,9 46,8 87.81% | 99,0 59,0 67.77% | 163 89,9 81.38% | 185 155 19.68% | 348 396 -12.08% | 250 101 146.5% | 205 | 228 | 183 | 303 | 324 | 331 | 337 | 274 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -349 -422 17.22% | -98,3 -84,9 -15.83% | -85,4 -97,3 12.28% | -184 -166 -10.64% | 20,9 -69,2 130.18% | 99,5 63,0 58.12% | 120 94,0 28.14% | 147 95,4 54.28% | 149 168 -11.02% | 296 406 -26.99% | 259 111 133.23% | 216 | 242 | 204 | 319 | 343 | 352 | 349 | |
|
Net income Million USD | Released Forecast Spread | -372 -438 15.17% | -121 -99,1 -22.42% | -152 -101 -49.96% | -273 -216 -26.5% | 1,27 -74,2 101.71% | 94,3 41,3 128.38% | 95,6 56,0 70.7% | 125 75,0 66.44% | 66,5 150 -55.57% | 191 363 -47.29% | 227 88,6 156.57% | 183 | 195 | 162 | 270 | 285 | 295 | 291 | |
|
EPS USD | Released Forecast Spread | -1,15 -0,99 -16.04% | -1,43 -1,07 -33.87% | 0,01 -0,74 101.35% | 0,84 0,31 169.31% | 1,09 0,64 70.85% | 0,58 1,22 -52.43% | 1,96 0,77 155.65% | 1,65 | 1,77 | 1,52 | 2,16 | 2,40 | 2,59 | 2,67 | |||||
| Announcement Date | 07/08/24 | 12/11/24 | 27/02/25 | 27/02/25 | 07/05/25 | 06/08/25 | 06/08/25 | 06/11/25 | 26/02/26 | 26/02/26 | 06/05/26 | - | - | - | - | - | - | - | - |
| 15/06/2026 | Information meeting | 07:30 pm | |
| 15/06/2026 | Information meeting | 05:30 pm | |
| 15/06/2026 | Annual General Meeting | 07:30 am | |
| 15/06/2026 | Présentation aux Actionnaires / Analystes | 01:30 pm | |
| 15/06/2026 | Extraordinary General Meeting | ||
| 15/06/2026 | Annual General Meeting | ||
| 16/06/2026 | Annual General Meeting | ||
| 17/06/2026 | Présentation aux Actionnaires / Analystes | 10:30 pm | |
| 17/06/2026 | Annual General Meeting | 10:30 pm | |
| 17/06/2026 | Présentation aux Actionnaires / Analystes | 02:00 am |
Past sector events for BeOne Medicines AG
| 12/06/2026 | Annual General Meeting | 07:00 pm | |
| 12/06/2026 | Annual General Meeting | 11:00 am | |
| 12/06/2026 | Information meeting | 05:30 pm | |
| 12/06/2026 | Présentation aux Actionnaires / Analystes | 01:30 am | |
| 12/06/2026 | Annual General Meeting | 01:30 am | |
| 12/06/2026 | Annual General Meeting | 07:30 am | |
| 11/06/2026 | Annual General Meeting | 09:00 pm | |
| 11/06/2026 | Présentation aux Actionnaires / Analystes | 09:00 pm | |
| 11/06/2026 | Présentation aux Actionnaires / Analystes | 07:30 pm | |
| 11/06/2026 | Annual General Meeting | 07:30 pm |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ONC Stock
- Calendar BeOne Medicines AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















